Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-21 · accession 0001773751-25-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-23 | 2025-01-21 | HIMS | Baird Melissa | COO | S - Sale+OE | $29.35 | -67.7K | 711.3K | -9% | -$1.99M |
| D | 2025-01-23 | 2025-01-21 | HIMS | Baird Melissa | COO | M - OptEx | $0.4 | +67.7K | 774.6K | +10% | +$27.1K |
| D | 2025-01-23 | 2025-01-21 | HIMS | Baird Melissa | COO | M - OptEx | $0.00 | -67.7K | 189.9K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-21 | S | D | 9,280 | $28.67 | 747,654 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.20- $28.975. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-01-21 | S | D | 13,430 | $29.58 | 756,934 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.00 - $29.95. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2025-01-21 | S | D | 4,195 | $28.57 | 770,364 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.025 - $28.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2025-01-21 | M | A | 67,687 | $0.4 | 774,559 | D | — | — | |
| 5 | Common | Class A Common Stock | 2025-01-21 | S | D | 31,845 | $29.55 | 715,809 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.00 - $29.96. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Class A Common Stock | 2025-01-21 | S | D | 4,476 | $29.72 | 706,872 | D | — | — | (F7) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.515- $29.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Class A Common Stock | 2025-01-21 | S | D | 4,461 | $29.05 | 711,348 | D | — | — | (F6) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.545 - $29.445. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Derivative | Stock Option (right to buy) | 2025-01-21 | M | D | 67,687 | $0.00 | 189,930 | D | $0.4 · — to 2028-03-28 | 67,687 Class A Common Stock | (F8) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. |